Senti Biosciences Stock Investor Sentiment

SNTI Stock  USD 2.12  0.06  2.75%   
Under 62% of Senti Biosciences' investor base is looking to short. The analysis of overall sentiment of trading Senti Biosciences stock suggests that many investors are alarmed at this time. Senti Biosciences' investing sentiment shows overall attitude of investors towards Senti Biosciences.
  
over three months ago at www.macroaxis.com         
Disposition of 315748 shares by Lu Timothy K of Senti Biosciences at 9.92 subject to Rule 16b-3
Macroaxis News
over three months ago at news.google.com         
Senti Biosciences announces 1-for-10 reverse stock split By Investing.com - Investing.com Nigeria
Google News at Macroaxis
over three months ago at finance.yahoo.com         
Senti Bio Announces Reverse Stock Split
Yahoo News
over three months ago at www.macroaxis.com         
Acquisition by Farokhzad Omid of 125000 shares of Senti Biosciences subject to Rule 16b-3
Macroaxis News
over three months ago at www.macroaxis.com         
Acquisition by James Collins of 62500 shares of Senti Biosciences at 0.31 subject to Rule 16b-3
Macroaxis News
over three months ago at news.google.com         
Acquisition by Cooperstone Brenda of 62500 shares of Senti Biosciences at 0.31 subject to Rule 16b-3
Google News at Macroaxis
over three months ago at finance.yahoo.com         
Senti Bio Awarded California Institute for Regenerative Medicines Grant for Clinical Development of ...
Yahoo News
over three months ago at benzinga.com         
Senti Bio Awarded California Institute for Regenerative Medicines Grant for Clinical Development of ...
benzinga news
over three months ago at globenewswire.com         
Senti Bio Awarded California Institute for Regenerative Medicines Grant for Clinical Development of ...
Macroaxis News: globenewswire.com
over three months ago at bizjournals.com         
Yael Weiss rare disease startup, Senti Bio cancer program win multimillion-dollar CIRM grants
bizjournals News
over three months ago at investorplace.com         
Why Is Senti Biosciences Stock Up 32 percent Today?
sbwire news
over three months ago at investorplace.com         
Why Is Faraday Future Stock Down 27 percent Today?
sbwire news
over three months ago at news.google.com         
Investors in Senti Biosciences have unfortunately lost 82 percent over the last year - Yahoo Movies ...
Google News at Macroaxis
over six months ago at news.google.com         
Senti Biosciences Shares Down 3.5 percent - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Kronos Bio Hires Ex-Senti Bio CFO to Head Finances, Operations - MarketWatch
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Senti Biosciences that are available to investors today. That information is available publicly through Senti media outlets and privately through word of mouth or via Senti internal channels. However, regardless of the origin, that massive amount of Senti data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Senti Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Senti Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Senti Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Senti Biosciences alpha.

Senti Biosciences Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Senti Stock analysis

When running Senti Biosciences' price analysis, check to measure Senti Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senti Biosciences is operating at the current time. Most of Senti Biosciences' value examination focuses on studying past and present price action to predict the probability of Senti Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senti Biosciences' price. Additionally, you may evaluate how the addition of Senti Biosciences to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Fundamental Analysis
View fundamental data based on most recent published financial statements
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities